Cardinal Health, Inc. (CAH) Stock

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Cardinal Health, Inc. is led by CEO Jason Hollar, employs 57,700 people, headquartered in Dublin, US, publicly traded since 1983.

Cardinal Health, Inc. (CAH) stock trades at $249.57 with a market capitalization of $57.79B. The stock is valued at a price-to-earnings (P/E) ratio of 34.08, a negative price-to-book of -20.28, reflecting negative shareholders' equity, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $157.79 and $259.02, and currently trades 3.6% below its 52-week high. It pays a dividend yielding 0.83%.

On profitability, Cardinal Health, Inc. generates a return on equity (ROE) of -59.73% (not meaningful, as shareholders' equity is negative), return on capital employed of 19.51%, an operating margin of 0.92%, a net profit margin of 0.67%.

In its most recent fiscal year, Cardinal Health, Inc. reported annual revenue of $254.2B, net profit of $1.7B. Over the last 5 fiscal years, revenue grew at an average annual rate of 9.4%, and net profit grew at an average annual rate of 22.9%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of -3.45 (negative because shareholders' equity is negative), a current ratio of 0.94, total assets of $57.3B, $4.9B in cash and equivalents.

CAH has an average daily trading volume of 2,013,414 shares, a beta of 0.50 (historically less volatile than the overall market).

Official website: www.cardinalhealth.com

Cardinal Health, Inc. by the numbers, 2017–2026

Between 2017 and 2026 Cardinal Health, Inc. reported revenue of $130.0B rising to $254.2B, a change of +95.6% across 10 years. Compounded, revenue has grown 9.4% a year over five years, 7.4% over three, 14.2% over the last twelve months. Net profit rose to $1.7B.

Operating margin went from 1.6% in 2017 to 1.0% in 2026, essentially unchanged. The most recent net margin is 0.67%. On a trailing twelve-month basis to Jun '26, revenue is $254.2B and net profit $1.7B.

Borrowings fell from $10.4B to $9.9B, cash from operations was $5.2B in the latest year, positive in 10 of the last 10.

Return on equity has averaged -4.2% over five years, and was -59.5% in the most recent year.

The share price itself has compounded at 34.8% a year over five years, 37.9% over three, 41.8% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Cardinal Health, Inc. (CAH) — frequently asked questions